Building an Adaptable Discovery Pipeline for the Evolving Antibody Therapeutic Landscape Abveris dives into the world of antibody therapeutics and the opportunities that could spawn from more agile antibody detection and discovery methods Colby Souders at Abveris (April 2021)
|